Parkinson's disease (PD) is the second-leading cause of dementia and is characterized by a progressive loss of dopaminergic neurons in the substantia nigra alongside the presence of …
R Franco, G Navarro - Frontiers in Pharmacology, 2023 - frontiersin.org
G protein-coupled receptors (GPCRs) are the target of hundreds of approved drugs. Although these drugs were designed to target individual receptors, it is becoming …
IV Romanova, KV Derkach, AL Mikhrina… - Neurochemical …, 2018 - Springer
Abstract The pro-opiomelanocortin (POMC)-expressing neurons of the hypothalamic arcuate nucleus (ARC) are involved in the control of food intake and metabolic processes. It is …
JL Conroy, RB Free, DR Sibley - ACS chemical neuroscience, 2015 - ACS Publications
The D1 dopamine receptor (D1R) has been implicated in numerous neuropsychiatric disorders, and D1R-selective ligands have potential as therapeutic agents. Previous studies …
A Hasbi, M Sivasubramanian, M Milenkovic… - Neurobiology of …, 2020 - Elsevier
Background Dopamine receptors interact with other receptors to form heterooligomers. One such complex, the D1-D2 heteromer, demonstrated in cultured striatal neurons and rat …
A role for the mesolimbic dopaminergic system in the pathophysiology of depression has become increasingly evident. Specifically, brain-derived neurotrophic factor (BDNF) has …
SA Kinlein, NK Wallace, MI Savenkova… - Neurobiology of …, 2022 - Elsevier
It is now well-established that stress elicits brain-and body-wide changes in physiology and has significant impacts on many aspects of health. The hypothalamic-pituitary-adrenal (HPA) …
Abstract Calcium ion (Ca2+) homeostasis is crucial for neuron function and neurotransmission. This study focused on the actions mediated by the CB1 receptor (CB1R) …
Biased signaling is a concept that has arisen in the G protein-coupled receptor (GCPR) research field, and holds promise for the development of new drug development strategies …